Stay updated on Safety of Risankizumab in Psoriasis: New Formulation Clinical Trial
Sign up to get notified when there's something new on the Safety of Risankizumab in Psoriasis: New Formulation Clinical Trial page.

Latest updates to the Safety of Risankizumab in Psoriasis: New Formulation Clinical Trial page
- ChecktodayNo Change Detected
- Check8 days agoChange DetectedThe page revision tag was updated to v3.6.6, replacing the previous v3.6.5, signaling a new release of the page’s content and UI. This change does not modify study details or user actions.SummaryDifference0.0%

- Check15 days agoNo Change Detected
- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedThe revision has been updated from v3.6.4 to v3.6.5, indicating a software version update behind the page. This change reflects an update to the platform's underlying codebase and does not alter study details or displayed content.SummaryDifference0.0%

- Check43 days agoChange DetectedThe page now displays Revision: v3.6.4, replacing the previous v3.6.3, indicating a recent page update. No study details or user-facing content appear to be modified.SummaryDifference0.0%

- Check65 days agoChange DetectedThe page's revision identifier was updated from v3.6.2 to v3.6.3, replacing the previous revision reference. This represents a minor version bump to the page/document rather than a change to visible content.SummaryDifference0.0%

- Check72 days agoChange DetectedThe revision tag on the page was updated from v3.6.0 to v3.6.2, signaling a minor software version update. No study details or public content appear to be altered by this change.SummaryDifference0.0%

- Check86 days agoChange DetectedNew navigation/help sections were added, including How to Read a Study Record, Common Questions, How to Join a Study, and a standardized Intervention/Treatment label. The page now shows recruitment status as No longer looking for participants, and the revision tag was updated from v3.5.5 to v3.6.0 while the older label variant was removed.SummaryDifference0.3%

Stay in the know with updates to Safety of Risankizumab in Psoriasis: New Formulation Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety of Risankizumab in Psoriasis: New Formulation Clinical Trial page.